Biologics

The California Institute for Regenerative Medicine could close after awarding all allocated funds, The Scientist reports.

A federal court ordered that Sunrise, Fla.-based regenerative medicine companies US Stem Cell Clinic and US Stem Cell stop providing stem cell treatments to patients, according to the U.S. Department of Justice.

NervGen Pharma will use its developing drug technology for spinal cord injuries in a new multiple sclerosis program.

Biologics therapies have the promise to revolutionize orthopedics and sports medicine, but unauthorized operators pose a serious threat to emerging therapies.

Orthobiologics company Cerapedics appointed Patrick O'Connor to serve as vice president of clinical and market development.

Chinese biologics technology company WuXi Biologics is expanding its conjugation solution center to include commercial manufacturing later this year.

AlloSource partnered with Manufacturing USA in a new public-private initiative, the Advanced Regenerative Manufacturing Institute.

Granite Creek Capital Partners, a private investment firm in Chicago, invested in regenerative medicine company Royal Biologics.

Orthopedic and sports medicine technology company Ortho Regenerative Technologies unveiled Claude LeDuc as its new president and CEO, according to Biospace.

Regenerative Medicine Minnesota is a bipartisan effort to improve research, technology, education and patient access to regenerative medicine-based treatments.